Kindred Biosciences Inc
Kindred Biosciences Stock Climbs After News of Elanco Purchase
Seth Klarman’s Baupost Group raises its stake in PBF Energy
The Baupost Group raised its stake in PBF Energy Inc. (PBF) by 1,021,466 shares to own 1,976,606 shares at the end of the fourth quarter.
The Baupost Group ups its stake in Idenix Pharmaceuticals
Idenix Pharmaceuticals (IDIX) accounted for a 6.25% position in Baupost’s fourth quarter portfolio. The hedge fund increased its stock holdings in Idenix last month.
The Baupost Group buys stake in Fidelity National Financial
Fidelity National Financial Inc. (FNF) is a new position initiated by The Baupost Group last quarter. The position accounts for 1.82% of the fund’s 4Q portfolio.
Seth Klarman’s Baupost Group buys stake in Kindred Biosciences
The Baupost Group opened a new position in animal health company Kindred Biosciences Inc. (KIN) that accounts for 0.92% of the fund’s $3.5 billion portfolio.
The Baupost Group buys a small position in Alon USA Partners
The Baupost Group added a small stake in Alon USA Partners LP (ALDW) that accounted for 0.16% of the fund’s total portfolio.
The Baupost Group’s 4Q13 positions: An investor’s must-know guide
Seth Klarman’s Baupost Group, LLC was ranked the fourth best-performing hedge fund manager of all time for generating $21.5 billion in returns over its history.